Effect of cyclin D1 on HBV transcription and replication

Siwen PENG; Guiwen GUAN; Ting ZHANG; Fengmin LU; Jia LIU; Xiangmei CHEN

doi:10.3969/j.issn.1001-5256.2023.02.010

Volume 39 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(2): 316-324

PDF( 5284 KB)

Effect of cyclin D1 on HBV transcription and replication

DOI: 10.3969/j.issn.1001-5256.2023.02.010

Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China

Research funding:

Beijing Natural Science Foundation (7222108)

More Information

Corresponding author: LIU jia, liujia2803@163.com (ORCID: 0000-0001-8485-5724); CHEN xiangmei, xm_chen6176@bjmu.edu.cn (ORCID: 0000-0003-0302-6866)
Received Date: 2022-07-04
Accepted Date: 2022-08-10
Published Date: 2023-02-20

Abstract

Abstract

Objective To investigate the effect of cyclin D1 (with CCND1 as the gene name) on HBV replication and its potential mechanism. Methods With reference to GSE84044 dataset, the Spearman's rank correlation analysis was used to investigate the correlation between the expression levels of genes in liver tissue and serum HBV DNA load in patients with HBV-related liver fibrosis. Cyclin D1 and cyclin D1 T286A mutant were transiently expressed in the HBV cell replication model, and time-resolved immunofluorescence and quantitative real-time PCR were used to measure the levels of HBsAg/HBeAg and HBV DNA in cell culture supernatant; Western blot was used to measure the level of HBV core protein in cells; reverse-transcription quantitative real-time PCR was used to measure the level of HBV RNA in cells; dual-luciferase reporter assay was used to observe the effect of cyclin D1 on the activity of HBV basic core promoter (BCP). GSE83148 dataset was used to investigate the correlation between CCND1 and HBV-related regulatory factors. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups. Results The analysis of GSE84044 data showed that 7 cell cycle genes were significantly negatively correlated with HBV DNA load in liver tissue of the patients with HBV-related liver fibrosis (all r < -0.3, all P < 0.05), which included the CCND1 gene (r=-0.474, P < 0.001). Exogenous expression of cyclin D1 and cyclin D1 T286A mutant reduced the levels of HBsAg, HBeAg, and HBV DNA in culture supernatant of the HBV replication cell model, as well as the levels of HBV core protein and HBV RNA in cells. Exogenous expression of cyclin D1 significantly inhibited the transcriptional activity of HBV BCP. The expression level of CCND1 in liver tissue of chronic hepatitis B patients was significantly positively correlated with the expression of APOBEC3G (r=0.575, P < 0.001), SMC5 (r=0.341, P < 0.001), and FOXM1 (r=0.333, P < 0.001) which inhibited HBV replication, while it was significantly negatively correlated with the expression of the HBV entry receptor NTCP (r=-0.511, P < 0.001) and HNF1α as the transcription factor for positive regulation of HBV replication (r=-0.430, P < 0.001). Overexpression of cyclin D1 in HepG2 cells reduced the transcriptional levels of HNF1α and NTCP. Conclusion Cyclin D1 inhibits HBV transcription and replication possibly by downregulating the expression of HNF1α and NTCP.
- Hepatitis B Virus,
- Cyclin D1,
- Virus Replication,
- Gene Transcription

FullText(HTML)

References(24)

References

[1]	GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 385(9963): 117-171. DOI: 10.1016/S0140-6736(14)61682-2.
[2]	Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007. 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
[3]	WANG J, HUANG H, LIU Y, et al. HBV genome and life cycle[J]. Adv Exp Med Biol, 2020, 1179: 17-37. DOI: 10.1007/978-981-13-9151-4_2.
[4]	XIA Y, CHENG X, LI Y, et al. Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype[J]. J Virol, 2018, 92(19): e00722-18. DOI: 10.1128/JVI.00722-18.
[5]	YANG Y, YAN Y, CHEN Z, et al. Histone deacetylase inhibitors romidepsin and vorinostat promote hepatitis B virus replication by inducing cell cycle arrest[J]. J Clin Transl Hepatol, 2021, 9(2): 160-168. DOI: 10.14218/JCTH.2020.00105.
[6]	OTTO T, SICINSKI P. Cell cycle proteins as promising targets in cancer therapy[J]. Nat Rev Cancer, 2017, 17(2): 93-115. DOI: 10.1038/nrc.2016.138.
[7]	TCHAKARSKA G, SOLA B. The double dealing of cyclin D1[J]. Cell Cycle, 2020, 19(2): 163-178. DOI: 10.1080/15384101.2019.1706903.
[8]	QI Z, LI G, HU H, et al. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice[J]. J Virol, 2014, 88(14): 8045-8056. DOI: 10.1128/JVI.01024-14.
[9]	WANG M, GONG Q, ZHANG J, et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis[J]. Sci Rep, 2017, 7: 43446. DOI: 10.1038/srep43446.
[10]	ZHOU W, MA Y, ZHANG J, et al. Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions[J]. Liver Int, 2017, 37(11): 1632-1641. DOI: 10.1111/liv.13427.
[11]	RITCHIE ME, PHIPSON B, WU D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): e47. DOI: 10.1093/nar/gkv007.
[12]	R Core Team (2022). R: A language and environment for statistical computing[EB/OL]. https://www.R-project.org/.
[13]	KANG J, WANG J, CHENG J, et al. Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance[J]. Oncotarget, 2017, 8(34): 56041-56050. DOI: 10.18632/oncotarget.10241.
[14]	JUNG YJ, KIM JW, PARK SJ, et al. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells[J]. J Med Virol, 2013, 85(6): 969-978. DOI: 10.1002/jmv.23534.
[15]	ALMAJHDI FN, AL-QUDARI AY, HUSSAIN Z. Differential expression of transforming growth factor-β1 and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines[J]. Ann Hepatol, 2013, 12(3): 408-415.
[16]	ALT JR, CLEVELAND JL, HANNINK M, et al. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation[J]. Genes Dev, 2000, 14(24): 3102-3114. DOI: 10.1101/gad.854900.
[17]	DIEHL JA, CHENG M, ROUSSEL MF, et al. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization[J]. Genes Dev, 1998, 12(22): 3499-3511. DOI: 10.1101/gad.12.22.3499.
[18]	YAN Y, ALLWEISS L, YANG D, et al. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection[J]. Emerg Microbes Infect, 2019, 8(1): 879-894. DOI: 10.1080/22221751.2019.1625728.
[19]	KÖNIG A, YANG J, JO E, et al. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells[J]. J Hepatol, 2019, 71(2): 289-300. DOI: 10.1016/j.jhep.2019.04.010.
[20]	ELLER C, HEYDMANN L, COLPITTS CC, et al. A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor[J]. Nat Commun, 2020, 11(1): 2707. DOI: 10.1038/s41467-020-16517-w.
[21]	RANEY AK, EASTON AJ, MILICH DR, et al. Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1[J]. J Virol, 1991, 65(11): 5774-5781. DOI: 10.1128/JVI.65.11.5774-5781.1991.
[22]	ZHENG Y, LI J, OU JH. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein[J]. J Virol, 2004, 78(13): 6908-6914. DOI: 10.1128/JVI.78.13.6908-6914.2004.
[23]	WANG WX, LI M, WU X, et al. HNF1 is critical for the liver-specific function of HBV enhancer Ⅱ[J]. Res Virol, 1998, 149(2): 99-108. DOI: 10.1016/s0923-2516(98)80085-x.
[24]	QUASDORFF M, HÖSEL M, ODENTHAL M, et al. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation[J]. Cell Microbiol, 2008, 10(7): 1478-1490. DOI: 10.1111/j.1462-5822.2008.01141.x.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(4)

Get Citation

PDF

XML

Article Metrics

Article views (571) PDF downloads(70)

Effect of cyclin D1 on HBV transcription and replication

DOI: 10.3969/j.issn.1001-5256.2023.02.010

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Effect of cyclin D1 on HBV transcription and replication

DOI: 10.3969/j.issn.1001-5256.2023.02.010

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content